{"database": "lobbying", "table": "lobbying_activities", "rows": [[4026696, "15281d24-137d-4afb-a536-c6d69c9f8667", "Q2", "MAGILL ASSOCIATES, LLC", 401103511, "THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES", 2026, "second_quarter", "MED", "FY 2027 appropriations for the development of a synthetic vaccine", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2026-07-07T10:35:39-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["4026696"], "units": {}, "query_ms": 0.188745791092515, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}